Sleep Duration Deemed Important in Breast CA Survival

Share this content:
Sleep Duration Deemed Important in Breast CA Survival
Sleep Duration Deemed Important in Breast CA Survival

FRIDAY, June 12, 2015 (HealthDay News) -- Breast cancer patients who had poor sleep and frequent snoring before their cancer diagnosis appear to have lower survival rates, according to new research. The study was presented at the annual meeting of the Associated Professional Sleep Societies (SLEEP 2015), held from June 6 to 10 in Seattle.

The study included 18,552 cancer patients whose progress was tracked in the Women's Health Initiative study. All of the women provided information about a number of aspects of their sleep prior to their cancer diagnosis, including the amount of sleep they got, whether or not they snored, and any history of insomnia.

Researchers led by Amanda Phipps, Ph.D., M.P.H., an assistant professor of epidemiology at the University of Washington in Seattle, found that women who slept six hours or less per night and were frequent snorers had more than twice the odds of a poor prognosis compared to women with neither of those factors. A similar finding was seen for women with lung cancer, although the effect was not as large as was seen in women with breast cancer, the study authors said.

"Our results suggest that sleep duration is important for breast cancer survival, particularly in women who snore," Phipps said in a news release from the American Academy of Sleep Medicine.

Abstract No. 0835
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths